Francisco Javier Escalada San Martín-rekin lankidetzan egindako argitalpenak (2)

2023

  1. Uroguanylin prevents hepatic steatosis, mitochondrial dysfunction and fibrosis in obesity-associated NAFLD

    Metabolism: Clinical and Experimental, Vol. 147

2022

  1. High plasma and lingual uroguanylin as potential contributors to changes in food preference after sleeve gastrectomy

    Metabolism: Clinical and Experimental, Vol. 128